Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Epoetin Alfa Deep Tank vs Roller Bottle in CKD
NCT00156962Phase 3Terminated
- Sponsor
- Amgen
- Start
- Apr 2005
- Primary completion
- Mar 2007
- Modality
- Biologic, rProtein (Recombinant Protein)
01
Overview
Phase 3, randomised, open-label trial of epoetin alfa in anemia (2 arms), sponsored by Amgen. Primary endpoint: Subject incidence of adverse events. Started Apr 2005; status: terminated.
02
Drugs
epoetin alfa
03
Conditions
anemia
Beyond the preview
Go deeper on NCT00156962.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00156962.